Loading insider details...
Beta
Latest Form 4 (Sep 22, 2026): Tax Withholding of 22,812 RNA shares, $204.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 22, 2026 | Atrium Therapeutics, Inc. (RNA) | Tax Withholding | 22,812 | $204.2K |
| Feb 27, 2026 | Avidity Biosciences, Inc. (RNAM) | Disposition to Issuer | 150,365 | n/a |
| Jan 23, 2026 | Avidity Biosciences, Inc. (RNA) | Sale | 3,976 | $288.1K |
| Jan 9, 2026 | Avidity Biosciences, Inc. (RNA) | Sale | 2,373 | $171.4K |
| Dec 19, 2025 | Avidity Biosciences, Inc. (RNA) | Grant/Award | 27,500 | n/a |
| Sep 12, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 20,000 | $284.4K |
| Jun 12, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 20,000 | $284.4K |
| Mar 21, 2025 | Avidity Biosciences, Inc. (RNA) | Sale | 11,780 | $365.9K |
| Mar 12, 2025 | Avidity Biosciences, Inc. (RNA) | Exercise/Conversion | 20,000 | $284.4K |
| Jan 24, 2025 | Avidity Biosciences, Inc. (RNA) | Sale | 3,860 | $110.4K |